Targeted inhibition of CD133+ cells in oral cancer cell lines. - Wikidata - awgldk - TriplyDB

Targeted inhibition of CD133+ cells in oral cancer cell lines.

Targeted inhibition of CD133+ cells in oral cancer cell lines.

http://www.wikidata.org/entity/Q35129213

about

Molecular Mechanisms and Potential Clinical Applications of Campylobacter jejuni Cytolethal Distending Toxin Targeting head and neck tumoral stem cells: From biological aspects to therapeutic perspectives Cancer stem cells--important players in tumor therapy resistance CD133/prominin-1-mediated autophagy and glucose uptake beneficial for hepatoma cell survival CD133, Selectively Targeting the Root of Cancer Cytolethal distending toxin B as a cell-killing component of tumor-targeted anthrax toxin fusion proteins.Targeting Head and Neck Cancer Stem Cells: Current Advances and Future Challenges Sensitization of radio-resistant prostate cancer cells with a unique cytolethal distending toxin.Development of chitosan/heparin nanoparticle-encapsulated cytolethal distending toxin for gastric cancer therapy.Linking stem cells to chromosomal instability.CD133: a cancer stem cells marker, is used in colorectal cancers.Cancer stem cells in human digestive tract malignancies.Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.Id1 and NF-κB promote the generation of CD133+ and BMI-1+ keratinocytes and the growth of xenograft tumors in mice.Aberrant expression of CD133 and musashi-1 in preneoplastic and neoplastic human oral squamous epithelium and their correlation with clinicopathological factors.Cancer stem cell markers in head and neck squamous cell carcinoma.Tetraspecific scFv construct provides NK cell mediated ADCC and self-sustaining stimuli via insertion of IL-15 as a cross-linker.Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia.Effects of a Phosphoinositide-3-Kinase Inhibitor on Anaplastic Thyroid Cancer Stem Cells Self-targeted salinomycin-loaded DSPE-PEG-methotrexate nanomicelles for targeting both head and neck squamous cell carcinoma cancer cells and cancer stem cells.Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity.

P2860

Q26767241-0384A60C-5F9F-4478-B1EA-13F36E7A2CDE Q26770039-D6E0083F-B9A1-4E0B-8F82-AA92FFAA5517 Q26823015-3B8A4F55-A092-40DA-9D3A-8119963C2FED Q27313878-B53CEB5E-E871-4D26-904E-B2323F963208 Q28066353-903B1125-C4F6-4848-A2F0-A30A5E105FE3 Q33694949-6FC5AB79-33C7-424F-9960-7FED7DAE6FB1 Q33793000-329EE64A-B919-4D93-91B5-C6CC2C5729C1 Q34221837-B9844ACF-5775-47E7-8B6A-D5232BD22012 Q34984874-938C724E-E415-48F8-94E4-460B4B64F898 Q36038443-D8E90818-4450-4D9D-B92C-FAD66950D773 Q36819568-C599555E-8FD8-49A0-A2AB-C28A8E13A360 Q38601789-0CDEB3A7-C6E4-4C50-AB40-EFB01B5B2357 Q38746734-3F58C9F7-A421-4066-BC7E-0B4E8753235D Q39020692-1EEF1E60-8961-43BF-909B-5F58E95C9793 Q39444412-7583B6D0-454A-4BE8-B40B-2EA600BE5D9D Q42006656-7B1B0BE7-FA24-4D4F-8E23-19A5770EC1CE Q42221543-75CA0163-2A3D-4A8B-B771-58FD99D84B85 Q45396030-68CCF5F1-BACE-4C41-B93E-725453D8C8BA Q47107349-BB36E4F9-45AC-4841-928C-92F217F8D7CD Q48868934-EB611E81-B22A-4B8D-A25A-00562D880FFD Q50992976-5F44B656-C15E-46E2-AB6F-2D55D584ABAC

P2860

Targeted inhibition of CD133+ cells in oral cancer cell lines.

http://www.wikidata.org/entity/Q35129213

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Targeted inhibition of CD133+ cells in oral cancer cell lines.

@ast

Targeted inhibition of CD133+ cells in oral cancer cell lines.

@en

type

label

Targeted inhibition of CD133+ cells in oral cancer cell lines.

@ast

Targeted inhibition of CD133+ cells in oral cancer cell lines.

@en

prefLabel

Targeted inhibition of CD133+ cells in oral cancer cell lines.

@ast

Targeted inhibition of CD133+ cells in oral cancer cell lines.

@en

P1433

Q35129213-9C2BC003-0D3F-4F46-ACF3-242BFAEAB030

P1476

Q35129213-538D28EB-DE6B-4B2D-BB75-5CF39E84605B

P2093

Q35129213-00621BCD-D21D-4850-9577-93220ECFBE1C

Q35129213-28FE4A91-12B8-4F47-B109-D6B063685674

Q35129213-3ABFE085-C20E-4E1B-978A-FA7AC3B08F77

Q35129213-77C4C05F-B8C3-4CB9-AA94-9B58A40D02BE

Q35129213-85F1F3FC-C6B7-4ED4-A976-637EE9D7B68A

Q35129213-9B5A7C83-8BF8-4447-B733-417FAF5BBD28

Q35129213-E8E30845-5D8D-4C3F-964C-178CE662049A

Q35129213-FF4BA1F2-29D7-4449-B28C-9459A4E168EE

P2860

Q35129213-0BF0095E-03B6-4229-AA88-52551780B22B

Q35129213-0EAA88DB-CD4F-4C46-B902-1DCF2E246502

Q35129213-18D8B819-77B6-4DCD-BA84-BC09DD1678B3

Q35129213-1A914F0C-05A7-4182-94B2-51E8C7B77E94

Q35129213-1D71131C-0A62-4C3A-A088-0B0737389FF2

Q35129213-212D86AD-E658-499C-8539-EFDD6CED6B0C

Q35129213-39B97821-00BA-4D4E-B3A5-50B944E849AB

Q35129213-3A82FA5E-F850-49C2-A43D-766C37968BBD

Q35129213-3F6F2D21-EFCC-4698-A46D-B78B7D76D121

Q35129213-428667E8-5B0F-476F-B305-C1F0A236DF16

P304

Q35129213-9825EF66-6633-4C19-84B6-BD517F131662

P31

Q35129213-CE048779-2AA1-405D-821C-AAA32F5AF377

P356

Q35129213-716F976A-5181-4E09-88E5-9D60A0232E5F

P407

Q35129213-5E4B9064-D910-4FB1-A3DD-3E9B23B6C671

P433

Q35129213-456FCAC9-E916-4038-AD20-EACF8BCCE85C

P478

Q35129213-849B0546-E783-4978-8F8A-C88555A6AF3F

P577

Q35129213-FBC323CC-05E5-4A51-AC4E-59462847F2DF

P5875

Q35129213-1638AFD9-A980-4E94-ACF9-E00F43B5BB84

P698

Q35129213-7D7ED0F6-A0A9-49D4-92A9-4520B6D35453

P932

Q35129213-E947BC27-D90B-444B-8A1B-6B4B7D7AE72F

P356

0022034510393511

P1433

Journal of Dental Research

P1476

Targeted inhibition of CD133+ cells in oral cancer cell lines.

@en

P2093

A Volgina

http://www.w3.org/2001/XMLSchema#string

B W O'Malley

http://www.w3.org/2001/XMLSchema#string

J Korostoff

http://www.w3.org/2001/XMLSchema#string

J M DiRienzo

http://www.w3.org/2001/XMLSchema#string

M Damek-Poprawa

http://www.w3.org/2001/XMLSchema#string

M S Brose

http://www.w3.org/2001/XMLSchema#string

S O Akintoye

http://www.w3.org/2001/XMLSchema#string

T P Sollecito

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase

UCSF Chimera--a visualization system for exploratory research and analysis

The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions

AC133/CD133/Prominin-1

Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

Study of the cytolethal distending toxin (CDT)-activated cell cycle checkpoint. Involvement of the CHK2 kinase.

Characterization of point mutations in the cdtA gene of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans.

Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma.

Immunotoxin treatment of cancer.

P304

638-645

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0022034510393511

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49741959

http://www.w3.org/2001/XMLSchema#string

P698

21220361

http://www.w3.org/2001/XMLSchema#string

P932

3144113

http://www.w3.org/2001/XMLSchema#string